HighTide Therapeutics Inc

HighTide Therapeutics Incverified

2511.HK

Price:

$3

Market Cap:

$1.56B

HighTide Therapeutics, Inc., an investment holding company, engages in the discovery, research and development, and commercialization of multifunctional therapies for the treatment of metabolic and digestive diseases with unmet medical needs. Its lead product candidate is HTD1801, a gut-liver anti-inflammatory metabolic modulator that targets metabolic dysfunction-associated steatohepatitis, type 2 diabetes mellitus, severe hypertriglyceridemia, primary sclerosing cholangitis, and primary biliary cholangitis. The company is also developing HTD4010, a polypeptide drug for the treatment of alcoholic hepatitis; HTD1804 to treat obesity; HTD1805, a multifunctional small molecule drug for the tre...[Read more]

Industry

Biotechnology

IPO Date

2023-12-22

Stock Exchange

HKSE

Ticker

2511.HK

The PE Ratio as of December 2025 (TTM) for HighTide Therapeutics Inc (2511.HK) is -4.23

According to HighTide Therapeutics Inc’s latest financial reports and current stock price. The company's current PE Ratio is -4.23. This represents a change of -98.87% compared to the average of -374.27 of the last 4 quarters.

HighTide Therapeutics Inc (2511.HK) Historical PE Ratio (quarterly & annually)

How has 2511.HK PE Ratio performed in the past?

The mean historical PE Ratio of HighTide Therapeutics Inc over the last ten years is -367.63. The current -4.23 PE Ratio has changed 15.06% with respect to the historical average. Over the past ten years (40 quarters), 2511.HK's PE Ratio was at its highest in in the June 2025 quarter at -2.27. The PE Ratio was at its lowest in in the December 2024 quarter at -789.08.

Quarterly (TTM)
Annual

Average

-367.63

Median

-26.52

Minimum

-1412.38

Maximum

-5.11

HighTide Therapeutics Inc (2511.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of HighTide Therapeutics Inc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 27.56%

Maximum Annual PE Ratio = -5.11

Minimum Annual Increase = -82.74%

Minimum Annual PE Ratio = -1412.38

Quarterly (TTM)
Annual
YearPE RatioChange
2024-1412.3827.56%
2023-5.11-82.74%
2022-29.5826.04%

HighTide Therapeutics Inc (2511.HK) Average PE Ratio

How has 2511.HK PE Ratio performed in the past?

The current PE Ratio of HighTide Therapeutics Inc (2511.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-482.35

5-year avg

-367.63

10-year avg

-367.63

HighTide Therapeutics Inc (2511.HK) PE Ratio vs. Peers

How is 2511.HK’s PE Ratio compared to its peers?

HighTide Therapeutics Inc’s PE Ratio is greater than SinoMab BioScience Limited (-10.41), less than Cutia Therapeutics (-3.74), greater than Mabpharm Limited (-80.44), greater than Zhaoke Ophthalmology Limited (-5.61), greater than Shanghai Bio-heart Biological Technology Co., Ltd. (-15.58), greater than Immunotech Biopharm Ltd (-6.56), less than JW (Cayman) Therapeutics Co. Ltd (-1.88), less than Frontage Holdings Corporation (72.18), greater than 3D Medicines Inc. (-6.75), less than Clover Biopharmaceuticals, Ltd. (-3.54),

Build a custom stock screener for HighTide Therapeutics Inc (2511.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HighTide Therapeutics Inc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

HighTide Therapeutics Inc (2511.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like HighTide Therapeutics Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is HighTide Therapeutics Inc's PE Ratio?

How is the PE Ratio calculated for HighTide Therapeutics Inc (2511.HK)?

What is the highest PE Ratio for HighTide Therapeutics Inc (2511.HK)?

What is the 3-year average PE Ratio for HighTide Therapeutics Inc (2511.HK)?

What is the 5-year average PE Ratio for HighTide Therapeutics Inc (2511.HK)?

How does the current PE Ratio for HighTide Therapeutics Inc (2511.HK) compare to its historical average?